Mussarat Ashraf
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mussarat Ashraf has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Rehana Rehman
Department of Biological & Biomedical Sciences, Aga Khan University, Karachi, Pakistan
8 shared publications - Arfa Azhar
Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan
4 shared publications - Haq Nawaz Khan
Department of Pathology and Laboratory Medicine The Aga Khan University Karachi Sindh Pakistan aku.edu
3 shared publications - Sumaira Riffat
Department of Physiology, Sindh Medical College, Jinnah Sindh Medical University, Karachi, Pakistan
3 shared publications - Hemaila Tariq
Department of Biological and Biomedical Sciences, Medical College, Aga Khan University, Karachi, Pakistan
2 shared publications - Adnan Munir
Department of Urology, Medical College, Liaquat National Hospital, Karachi, Pakistan
1 shared publication
Latest Publications
- Open Access
- 30 June 2025
- Published by Pakistan Physiological Society in Pakistan Journal of Physiology
- Vol. 21 (2) , 16-20
OXIDATIVE CAPACITY IN POLYCYSTIC OVARY SYNDROME: EXPLORATION AND WAY FORWARD
Background: Polycystic ovarian syndrome (PCOS) is a complex disorder characterized by elevated androgen levels, ovarian cysts, chronic anovulation, and infertility, with insulin resistance and hyperinsulinemia as key contributors. The study aims to explore the role of oxidative capacity in presentation of PCOS by estimating Total Oxidant Status (TOS), Alarin, and Fetuin in PCOS and non-PCOS infertile women. Methods: This cross-sectional study was conducted from Feb 2021 to Feb 2023. The study recruited 89 women with primary infertility aged 15-49 years. Participants were matched based on age and BMI, including women with a BMI ranging from normal to overweight/obese, while excluding those with secondary infertility, major health conditions, or oral contraceptive use. Healthy infertile women with regular cycles served as controls. Serum levels of TOS, Alarin, and Fetuin-A were measured using ELISA kits. Statistical analysis was performed using SPSS-23. Results: Forty-five (51%) of the participants had PCOS, with significantly higher BMI (p=0.002). Follicular Stimulating Hormone (FSH) and Latinizing Hormone (LH) levels were significantly elevated (p<0.001) in the PCOS group, while Anti-Mülarian Hormone (AMH) was significantly lower (p<0.001). Prolactin, vitamin D, and oxidative stress markers were comparable in both groups and were not significantly different as compared to the fertile females. The Spearman’s correlation computed that Prolactin significantly and negatively correlated with Fetuin-A and TOS, while positive correlations were found between Fetuin-A, Alarin, and TOS (p<0.001). Conclusion: Our findings suggest a potential link between oxidative stress and PCOS, highlighting its complexity. Pak J Physiol 2025;21(2):16-20, DOI: https://doi.org/10.69656/pjp.v21i2.1810
- 30 June 2025
- Published by Pakistan Physiological Society in Pakistan Journal of Physiology
- Vol. 21 (2) , 16-20
Open AccessOXIDATIVE CAPACITY IN POLYCYSTIC OVARY SYNDROME: EXPLORATION AND WAY FORWARD
Background: Polycystic ovarian syndrome (PCOS) is a complex disorder characterized by elevated androgen levels, ovarian cysts, chronic anovulation, and infertility, with insulin resistance and hyperinsulinemia as key contributors. The study aims to explore the role of oxidative capacity in presentation of PCOS by estimating Total Oxidant Status (TOS), Alarin, and Fetuin in PCOS and non-PCOS infertile women. Methods: This cross-sectional study was conducted from Feb 2021 to Feb 2023. The study recruited 89 women with primary infertility aged 15-49 years. Participants were matched based on age and BMI, including women with a BMI ranging from normal to overweight/obese, while excluding those with secondary infertility, major health conditions, or oral contraceptive use. Healthy infertile women with regular cycles served as controls. Serum levels of TOS, Alarin, and Fetuin-A were measured using ELISA kits. Statistical analysis was performed using SPSS-23. Results: Forty-five (51%) of the participants had PCOS, with significantly higher BMI (p=0.002). Follicular Stimulating Hormone (FSH) and Latinizing Hormone (LH) levels were significantly elevated (p<0.001) in the PCOS group, while Anti-Mülarian Hormone (AMH) was significantly lower (p<0.001). Prolactin, vitamin D, and oxidative stress markers were comparable in both groups and were not significantly different as compared to the fertile females. The Spearman’s correlation computed that Prolactin significantly and negatively correlated with Fetuin-A and TOS, while positive correlations were found between Fetuin-A, Alarin, and TOS (p<0.001). Conclusion: Our findings suggest a potential link between oxidative stress and PCOS, highlighting its complexity. Pak J Physiol 2025;21(2):16-20, DOI: https://doi.org/10.69656/pjp.v21i2.1810
- Open Access
- 20 September 2024
- Published by Springer Nature in Discover Public Health
- Vol. 21 (1) , 1-12
Unlocking the genetic mysteries: navigating VDR polymorphisms in polycystic ovary syndrome: a narrative review
- 20 September 2024
- Published by Springer Nature in Discover Public Health
- Vol. 21 (1) , 1-12
Open AccessUnlocking the genetic mysteries: navigating VDR polymorphisms in polycystic ovary syndrome: a narrative review
- 23 October 2023
- Published by Springer Nature in Biochemical Genetics
- Vol. 62 (3) , 2148-2165
Unraveling the Genetic Associations of DENND1A (rs9696009) and ERBB4 (rs2178575) with Infertile Polycystic Ovary Syndrome Females in Pakistan
Polycystic Ovary Syndrome (PCOS) is a complex genetic disorder in reproductive-aged women which is associated with comorbidities of reproductive, metabolic, cardiovascular, endocrine, and psychological nature. PCOS is the most common cause of anovulatory infertility. Pathogenesis of PCOS involves strong interaction between environmental and genetic factors. Many Single-Nucleotide Polymorphisms (SNPs) have been associated with PCOS in different populations. Currently, very limited association studies of PCOS and infertility have been done on Pakistani population. The variants DENND1A rs9696009 and ERBB4 rs2178575 are significantly associated with PCOS in Chinese and European populations. These candidate genes regulate the production of androgen hormone, Anti-Mullerian Hormone (AMH), and luteinizing hormone. All these hormones are involved pathogenesis of PCOS and infertility. The aim of the study is to find an association of DENND1A rs9696009 and ERBB4 rs2178575 variants with PCOS in infertile Pakistani females. In this case–control study, 300 infertile females were recruited. The cases (n = 160) were infertile female diagnosed with PCOS (Rotterdam Criteria), and controls (n = 140) were infertile women with no evidence of PCOS. The genomic DNA was isolated, and genotyping was done by PCR-Restriction fragment length polymorphism and further validated by DNA Sanger Sequencing. The Chi-Square analysis showed rs2178575 (ERBB4) was significantly associated with infertility (χ2 = 10.282, p = 0.005852) while rs9696009 (DENND1A) did not show any significant association (χ2 = 3.10, p = 0.212036). Furthermore, multinomial logistic regression analysis was performed and revealed that rs2178575 (ERBB4) heterozygous genotypes (GA) and mutant genotypes (AA) decrease the risk of infertility by 0.541 times (OR = 0.541, 95% CI = 0.314–0.930, p = 0.026) and 0.416 times (OR = 0.416, 95% CI = 0.228–0.757, p = 0.004), respectively, compared to wild-type genotype (GG). The ERBB4 variant is significantly associated with PCOS infertile women and genetically indicated that ERBB4 (rs2178575) decreases the risk of infertility in females having PCOS.
- 23 October 2023
- Published by Springer Nature in Biochemical Genetics
- Vol. 62 (3) , 2148-2165
Unraveling the Genetic Associations of DENND1A (rs9696009) and ERBB4 (rs2178575) with Infertile Polycystic Ovary Syndrome Females in Pakistan
Polycystic Ovary Syndrome (PCOS) is a complex genetic disorder in reproductive-aged women which is associated with comorbidities of reproductive, metabolic, cardiovascular, endocrine, and psychological nature. PCOS is the most common cause of anovulatory infertility. Pathogenesis of PCOS involves strong interaction between environmental and genetic factors. Many Single-Nucleotide Polymorphisms (SNPs) have been associated with PCOS in different populations. Currently, very limited association studies of PCOS and infertility have been done on Pakistani population. The variants DENND1A rs9696009 and ERBB4 rs2178575 are significantly associated with PCOS in Chinese and European populations. These candidate genes regulate the production of androgen hormone, Anti-Mullerian Hormone (AMH), and luteinizing hormone. All these hormones are involved pathogenesis of PCOS and infertility. The aim of the study is to find an association of DENND1A rs9696009 and ERBB4 rs2178575 variants with PCOS in infertile Pakistani females. In this case–control study, 300 infertile females were recruited. The cases (n = 160) were infertile female diagnosed with PCOS (Rotterdam Criteria), and controls (n = 140) were infertile women with no evidence of PCOS. The genomic DNA was isolated, and genotyping was done by PCR-Restriction fragment length polymorphism and further validated by DNA Sanger Sequencing. The Chi-Square analysis showed rs2178575 (ERBB4) was significantly associated with infertility (χ2 = 10.282, p = 0.005852) while rs9696009 (DENND1A) did not show any significant association (χ2 = 3.10, p = 0.212036). Furthermore, multinomial logistic regression analysis was performed and revealed that rs2178575 (ERBB4) heterozygous genotypes (GA) and mutant genotypes (AA) decrease the risk of infertility by 0.541 times (OR = 0.541, 95% CI = 0.314–0.930, p = 0.026) and 0.416 times (OR = 0.416, 95% CI = 0.228–0.757, p = 0.004), respectively, compared to wild-type genotype (GG). The ERBB4 variant is significantly associated with PCOS infertile women and genetically indicated that ERBB4 (rs2178575) decreases the risk of infertility in females having PCOS.
- 26 July 2023
- Published by Taylor & Francis in Nucleosides, Nucleotides & Nucleic Acids
- Vol. 43 (2) , 116-133
Genetic association of vitamin D receptor gene with female infertility
BackgroundInfertility is defined as failure to achieve a clinical pregnancy after 12 months of unprotected intercourse. It affects 15% of couples globally and 22% of couples within Pakistan. Female infertility can be caused by numerous genetic or environmental factors including hormone imbalances and exposure to chemicals or radiation. The prevalence of vitamin D deficiency among the adult population was reported to be 14-59% with a higher prevalence in Asian countries. Furthermore, the expression of Vitamin D receptor (VDR) can play a vital role in the reproductive organs of females. Hence, the aim of our present study was to check the association of VDR polymorphisms with infertile females. For this purpose, blood samples were collected for genotyping of four known VDR mutations [FokI (rs2228570), TaqI (rs731236), ApaI (rs7975232), and BsmI (rs1544410)] via PCR-based RFLP assay.ResultsGenotyping indicated that FokI, TaqI, and ApaI are associated with infertility (p = 0.004*, p = 0.013*, and p = 0.033*, respectively). However, BsmI did not show any significance. Multinomial regression analysis indicated that FokI heterozygous genotypes increase the risk of infertility by 2.5 times (hetero: OR = 2.5, 95%, p = 0.001*) as compared to wild type. Heterozygous genotypes of TaqI and ApaI were found to play a protective role and reduce the risk of infertility by 58 and 52%, respectively [TaqI: OR = 0.42, 95%, p = 0.004*, ApaI: OR = 0.48, 95%, p = 0.01*, respectively] as compared to wild type. Multinomial logistic regression analysis was also performed for allelic data as well.ConclusionThus, it could be summarized that among the studied polymorphisms of VDR, FokI SNP greatly increased the risk of infertility, while TaqI and ApaI genotypes protect from infertility. However, BsmI does not influence the risk of infertility in Pakistani females.
- 26 July 2023
- Published by Taylor & Francis in Nucleosides, Nucleotides & Nucleic Acids
- Vol. 43 (2) , 116-133
Genetic association of vitamin D receptor gene with female infertility
BackgroundInfertility is defined as failure to achieve a clinical pregnancy after 12 months of unprotected intercourse. It affects 15% of couples globally and 22% of couples within Pakistan. Female infertility can be caused by numerous genetic or environmental factors including hormone imbalances and exposure to chemicals or radiation. The prevalence of vitamin D deficiency among the adult population was reported to be 14-59% with a higher prevalence in Asian countries. Furthermore, the expression of Vitamin D receptor (VDR) can play a vital role in the reproductive organs of females. Hence, the aim of our present study was to check the association of VDR polymorphisms with infertile females. For this purpose, blood samples were collected for genotyping of four known VDR mutations [FokI (rs2228570), TaqI (rs731236), ApaI (rs7975232), and BsmI (rs1544410)] via PCR-based RFLP assay.ResultsGenotyping indicated that FokI, TaqI, and ApaI are associated with infertility (p = 0.004*, p = 0.013*, and p = 0.033*, respectively). However, BsmI did not show any significance. Multinomial regression analysis indicated that FokI heterozygous genotypes increase the risk of infertility by 2.5 times (hetero: OR = 2.5, 95%, p = 0.001*) as compared to wild type. Heterozygous genotypes of TaqI and ApaI were found to play a protective role and reduce the risk of infertility by 58 and 52%, respectively [TaqI: OR = 0.42, 95%, p = 0.004*, ApaI: OR = 0.48, 95%, p = 0.01*, respectively] as compared to wild type. Multinomial logistic regression analysis was also performed for allelic data as well.ConclusionThus, it could be summarized that among the studied polymorphisms of VDR, FokI SNP greatly increased the risk of infertility, while TaqI and ApaI genotypes protect from infertility. However, BsmI does not influence the risk of infertility in Pakistani females.
- Open Access
- 19 May 2023
- Published by Springer Nature in Research Square
Efficacy of vitamin D supplementation and metformin compared to metformin alone in infertile females with polycystic ovary syndrome: a randomized open label trial.
Background: WHO has declared Infertility as the fifth-highest serious global disability with prevalence of approximately 22% in Pakistan; 80% due to polycystic ovarian syndrome (PCOS). PCOS is characterized by “the presence of any two out of three criteria, that is oligo and/or anovulation, excess androgen activity and/or polycystic ovarian morphology on ultrasound”. Vitamin D deficiency (VDD) [serum 25(OH) D <20 ng/ml] is vital for female health and becoming public health problem even in sun-drenched cities. With high prevalence (58%) of VDD in Pakistani PCOS. The hypothesis: “VD supplementation can improve fertility by correcting in IR, ovulatory dysfunction, endometrial thickness and hyperandrogenism in primary infertile PCOS patients of our population”. We aim to evaluate impact of oral VD supplementation on fertility potential of VDD PCOS (VD <20 ng/ml) in a 2-years randomized clinical trial; Group-1 VDD control PCOS (n=100) and Group-2 VDD intervention group (n=100). Group-1will receive 1.5 g/day metformin therapy for 24 weeks. Group-2 will be given 50,000 I.U of VD once weekly for 8 weeks, followed by 50,000 I.U once every fortnight from 9- 24 weeks plus metformin therapy. Impact will be assessed by comparing trans-vaginal ultrasound (TVS; Day 12) at the start with TVS at end point (24 weeks) to observe change in dominantfollicle size (≥14 mm) and endometrial thickness (≥8 mm). Discussion: The proposed interventions will help to evaluate the impact of vitamin D supplementation on follicular maturation and endometrial thickness and PCOS parameters including lipid index and insulin resistance. Trial registration: ClinicalTrials.gov, NCT03989778
- 19 May 2023
- Published by Springer Nature in Research Square
Open AccessEfficacy of vitamin D supplementation and metformin compared to metformin alone in infertile females with polycystic ovary syndrome: a randomized open label trial.
Background: WHO has declared Infertility as the fifth-highest serious global disability with prevalence of approximately 22% in Pakistan; 80% due to polycystic ovarian syndrome (PCOS). PCOS is characterized by “the presence of any two out of three criteria, that is oligo and/or anovulation, excess androgen activity and/or polycystic ovarian morphology on ultrasound”. Vitamin D deficiency (VDD) [serum 25(OH) D <20 ng/ml] is vital for female health and becoming public health problem even in sun-drenched cities. With high prevalence (58%) of VDD in Pakistani PCOS. The hypothesis: “VD supplementation can improve fertility by correcting in IR, ovulatory dysfunction, endometrial thickness and hyperandrogenism in primary infertile PCOS patients of our population”. We aim to evaluate impact of oral VD supplementation on fertility potential of VDD PCOS (VD <20 ng/ml) in a 2-years randomized clinical trial; Group-1 VDD control PCOS (n=100) and Group-2 VDD intervention group (n=100). Group-1will receive 1.5 g/day metformin therapy for 24 weeks. Group-2 will be given 50,000 I.U of VD once weekly for 8 weeks, followed by 50,000 I.U once every fortnight from 9- 24 weeks plus metformin therapy. Impact will be assessed by comparing trans-vaginal ultrasound (TVS; Day 12) at the start with TVS at end point (24 weeks) to observe change in dominantfollicle size (≥14 mm) and endometrial thickness (≥8 mm). Discussion: The proposed interventions will help to evaluate the impact of vitamin D supplementation on follicular maturation and endometrial thickness and PCOS parameters including lipid index and insulin resistance. Trial registration: ClinicalTrials.gov, NCT03989778
- Open Access
- 1 January 2022
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 52 (6) , 1793-1801
Association of trinucleotide repeat polymorphisms CAG and GGC in exon 1 of the androgen receptor gene with male infertility: a cross-sectional study
Background/aim: Infertility is a global problem that brings about serious sexual and social consequences that strain the health sector and society. The expansion of CAG and GGC repeats in androgen receptor (AR) gene (Ensembl number ENSG00000169083) may lead to reduced fertility. Our objective was to determine the association of CAG and GGC repeats with altered sperm parameters in male infertile subjects. Materials and methods: This was a cross-sectional study conducted at Aga Khan University, Karachi, Pakistan. A total of 376 males were recruited, out of which group A (N = 208) and group B (N = 168) were comprised of subjects with normal and altered sperm parameters, respectively, from 18 to 60 years. The numbers of CAG and GGC repeats were determined by using PCR amplification and sequence analysis using the Molecular Evolutionary Genetic Analysis (MEGA) software version 6.0. Statistical analysis was performed using the SPSS version 20 and the P-value of <0.05 was considered significant. Results: The mean androgen receptor gene CAG repeats were significantly longer in males with altered sperm parameters as compared to male subjects with normal sperm parameters (P < 0.001). There was no significant difference found for GGC repeats for subjects with altered sperm parameters. Conclusion: Longer CAG length corresponded to greater severity of spermatogenic defect and may lead to subfertility recommendations.
- 1 January 2022
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 52 (6) , 1793-1801
Open AccessAssociation of trinucleotide repeat polymorphisms CAG and GGC in exon 1 of the androgen receptor gene with male infertility: a cross-sectional study
Background/aim: Infertility is a global problem that brings about serious sexual and social consequences that strain the health sector and society. The expansion of CAG and GGC repeats in androgen receptor (AR) gene (Ensembl number ENSG00000169083) may lead to reduced fertility. Our objective was to determine the association of CAG and GGC repeats with altered sperm parameters in male infertile subjects. Materials and methods: This was a cross-sectional study conducted at Aga Khan University, Karachi, Pakistan. A total of 376 males were recruited, out of which group A (N = 208) and group B (N = 168) were comprised of subjects with normal and altered sperm parameters, respectively, from 18 to 60 years. The numbers of CAG and GGC repeats were determined by using PCR amplification and sequence analysis using the Molecular Evolutionary Genetic Analysis (MEGA) software version 6.0. Statistical analysis was performed using the SPSS version 20 and the P-value of <0.05 was considered significant. Results: The mean androgen receptor gene CAG repeats were significantly longer in males with altered sperm parameters as compared to male subjects with normal sperm parameters (P < 0.001). There was no significant difference found for GGC repeats for subjects with altered sperm parameters. Conclusion: Longer CAG length corresponded to greater severity of spermatogenic defect and may lead to subfertility recommendations.
- 1 November 2021
- Published by Elsevier in Journal of Gynecology Obstetrics and Human Reproduction
- Vol. 50 (9) , 102157
Endometriosis, infertility and MicroRNA's: A review
- 1 November 2021
- Published by Elsevier in Journal of Gynecology Obstetrics and Human Reproduction
- Vol. 50 (9) , 102157
Endometriosis, infertility and MicroRNA's: A review
- 30 October 2020
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 75 (3) , e13790
Estimation of folic acid/micro nutrients levels; Does it reflect sperm parameters
Objective To study the impact of vitamin B12, folic acid (FA) and methylmalonic acid (MMA) on sperm parameters; count, motility and morphology leading to male fertility. Methods The cross‐sectional study comprised of one hundred and eighty‐six subjects with normal sperm parameters (fertile) and eighty‐eight subjects with abnormal sperm parameters labelled as ‘infertile’ from a sample population of Karachi, Pakistan. Vitamin B12, FA and MMA levels in serum were analyzed by enzyme linked immune sorbent assay. Unadjusted and adjusted prevalence ratio with their 95% CI were reported by using cox regression algorithm to assess the association of Vitamin B12, FA and MMA and other factors with male Infertility. Unadjusted and adjusted beta coefficients with 95% CI were reported by using linear regression analysis for assessing relationship of Vitamin B12, FA and MMA and other factors with semen parameters (count, motility and morphology); p value of < 0.05 was considered significant. Results It was declared that with every 1 unit increase in vitamin B12, FA and MMA the prevalence of infertility was decreased by 1%, 17% and 74% respectively. Multivariate analysis revealed that vitamin B12, FA and MMA had a significant association with total sperm count, motility and morphology. The sperm parameters were also affected by increase in; LH, BMI and body fat %. There was a significant positive correlation of; LH with Vitamin B12 and FA (0.423<0.001,0.338 <0.001) and testosterone with vitamin B12 and FA (0.326<0.001,0.291<0.001) respectively. Conclusion All the studied micronutrients; Vitamin B12, FA and MMA had a positive effect on sperm parameters; count, motility and morphology and the associated reproductive hormones which explains their role on reproductive functions required to acquire fertility
- 30 October 2020
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 75 (3) , e13790
Estimation of folic acid/micro nutrients levels; Does it reflect sperm parameters
Objective To study the impact of vitamin B12, folic acid (FA) and methylmalonic acid (MMA) on sperm parameters; count, motility and morphology leading to male fertility. Methods The cross‐sectional study comprised of one hundred and eighty‐six subjects with normal sperm parameters (fertile) and eighty‐eight subjects with abnormal sperm parameters labelled as ‘infertile’ from a sample population of Karachi, Pakistan. Vitamin B12, FA and MMA levels in serum were analyzed by enzyme linked immune sorbent assay. Unadjusted and adjusted prevalence ratio with their 95% CI were reported by using cox regression algorithm to assess the association of Vitamin B12, FA and MMA and other factors with male Infertility. Unadjusted and adjusted beta coefficients with 95% CI were reported by using linear regression analysis for assessing relationship of Vitamin B12, FA and MMA and other factors with semen parameters (count, motility and morphology); p value of < 0.05 was considered significant. Results It was declared that with every 1 unit increase in vitamin B12, FA and MMA the prevalence of infertility was decreased by 1%, 17% and 74% respectively. Multivariate analysis revealed that vitamin B12, FA and MMA had a significant association with total sperm count, motility and morphology. The sperm parameters were also affected by increase in; LH, BMI and body fat %. There was a significant positive correlation of; LH with Vitamin B12 and FA (0.423<0.001,0.338 <0.001) and testosterone with vitamin B12 and FA (0.326<0.001,0.291<0.001) respectively. Conclusion All the studied micronutrients; Vitamin B12, FA and MMA had a positive effect on sperm parameters; count, motility and morphology and the associated reproductive hormones which explains their role on reproductive functions required to acquire fertility
- 1 January 2020
- Published by Pakistan Medical Association in Journal of the Pakistan Medical Association
- Vol. 70 (3) , 461-466
Oxidative stress and male infertility: a cross sectional study
Objective: To compare stress markers and antioxidants in fertile and infertile males, and to explore their effects on reproductive hormones and fertility. Methods: The cross-sectional case-control study was conducted from July 2017 to July 2018 at the Islamabad Clinic Serving Infertile Couples, Islamabad, Pakistan, and comprised male subjects aged 25-55 years. Infertile subjects were the cases, while healthy fertile males acted as the controls. Stress hormones cortisol and adrenaline and antioxidants glutathione peroxidase and superoxide dismutase were measured using enzyme-linked immunosorbent assay. Data was analysed using SPSS 22. Results: Of the 376 subjects, 241(64%) were cases and 135(36%) were controls. Median cortisol, adrenaline, superoxide dismutase and glutathione levels were significantly higher among the cases compared to te controls (p<0.05). Follicle stimulating hormone and luteinizing hormone levels were higher in cases compared to the controls (p=0.05). Mean testosterone level was higher among the controls than the cases (p<0.001). After adjusting for other covariates, every increase of 7 units in cortisol increased the prevalence of infertility by 3% (p=0.001). There was significant interaction between luteinizing hormone and testosterone in the final model (p<0.05). Conclusion: Stress together with decrease in antioxidants was found to play a significant role in reducing the fertilising potential of male infertile subjects.
- 1 January 2020
- Published by Pakistan Medical Association in Journal of the Pakistan Medical Association
- Vol. 70 (3) , 461-466
Oxidative stress and male infertility: a cross sectional study
Objective: To compare stress markers and antioxidants in fertile and infertile males, and to explore their effects on reproductive hormones and fertility. Methods: The cross-sectional case-control study was conducted from July 2017 to July 2018 at the Islamabad Clinic Serving Infertile Couples, Islamabad, Pakistan, and comprised male subjects aged 25-55 years. Infertile subjects were the cases, while healthy fertile males acted as the controls. Stress hormones cortisol and adrenaline and antioxidants glutathione peroxidase and superoxide dismutase were measured using enzyme-linked immunosorbent assay. Data was analysed using SPSS 22. Results: Of the 376 subjects, 241(64%) were cases and 135(36%) were controls. Median cortisol, adrenaline, superoxide dismutase and glutathione levels were significantly higher among the cases compared to te controls (p<0.05). Follicle stimulating hormone and luteinizing hormone levels were higher in cases compared to the controls (p=0.05). Mean testosterone level was higher among the controls than the cases (p<0.001). After adjusting for other covariates, every increase of 7 units in cortisol increased the prevalence of infertility by 3% (p=0.001). There was significant interaction between luteinizing hormone and testosterone in the final model (p<0.05). Conclusion: Stress together with decrease in antioxidants was found to play a significant role in reducing the fertilising potential of male infertile subjects.